Global Community

Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed Momentum Vita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and supplements across the Asia-Pacific region. Founded in 1947, the company boasts strong brand recognition through its labels such as VitaHealth, Herbs of Gold, VitaScience, and VitaLife, offering over 350 premium healthcare and pharmaceutical products.

The quality of earnings generated by D-Link is good; it's nearly debt-free, and the Promoter has not reduced its stake from 51%. The company has shown consistent profitability and revenue growth, showcasing expansion in the market.

Overview: Africa Prudential delivered a strong first-half performance in 2025, growing profit after tax by 72.6% YoY to ₦1.35 billion, largely on the back of a surge in interest income and improved revenue from contracts with customers. However, rising operating expenses, significant drawdown in cash position, and elevated customer deposit liabilities present risks to liquidity and capital efficiency.

tel Corporation (INTC) might be considered undervalued for several reasons, depending on the perspective of investors and analysts. Some potential reasons include: Market Sentiment and Competition : Intel has faced increased competition from companies like AMD and NVIDIA, which have eaten into its market share, particularly in CPUs and GPUs. This has led to negative market sentiment despite Intel’s continued dominance in certain sectors, such as data centers.

Recent Financial Performance In H1 2025, Rovi’s net profit dropped by 10% to €39.7 million. The decline was mainly due to reduced third-party manufacturing, especially COVID-19 vaccine production.

Transcorp Hotels Plc continues to deliver robust growth in revenue and profit , bolstered by operating leverage, efficient cost control, and a strong balance sheet. The company recorded a 60% YoY revenue increase in H1 2025 and a 31% surge in net profit , underpinned by post-pandemic demand resurgence, effective expense management, and low gearing.

R.T. Briscoe Nigeria Plc showed improved top-line performance in H1 2025, with revenue rising by 62% year-on-year to ₦16.32 billion, driven by recovery in sales volume and market demand. Operating profit also increased modestly, but the company’s structural weaknesses and balance sheet fragility continue to weigh on its long-term viability.

The upcoming Kyivstar listing is far more than a financial transaction. By carving out Ukraine’s leading mobile and digital player and floating it on Nasdaq through a reputable partner like Cohen Circle Acquisition Corp.

If earnings hit half of what they were when the company founded in 2016, which was a reasonable housing market period, the company will profit around half a billion SEK. With a P/E multiple of 14, that is around 7 billion sek, which is 3 times the current market value.